Dexcom (DXCM) Assets (2010 - 2026)

Dexcom (DXCM) has 17 years of Assets data on file, last reported at $6.6 billion in Q1 2026.

• Assets for Q1 2026 came in at $6.6 billion, down 1.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.6 billion (down 1.75% YoY), and the FY2025 annual result was $6.3 billion, down 2.23% from the prior year.
• Assets climbed to $6.6 billion in Q1 2026 per DXCM's latest filing, from $6.3 billion in the prior quarter.
• Over five years, Assets peaked at $7.5 billion in Q3 2025 and troughed at $4.9 billion in Q3 2022.
• A 5-year average of $6.3 billion and a median of $6.5 billion in 2024 frame the typical range for Assets.
• The sharpest annual moves came in 2023 and 2024: Assets surged 34.64% in 2023, then dropped 3.67% in 2024.
• A 5-year view of Assets shows it stood at $5.4 billion in 2022, then increased by 16.19% to $6.3 billion in 2023, then increased by 3.51% to $6.5 billion in 2024, then slipped by 2.23% to $6.3 billion in 2025, then grew by 4.63% to $6.6 billion in 2026.
• Business Quant data shows DXCM's Assets at $6.6 billion in Q1 2026, $6.3 billion in Q4 2025, and $7.5 billion in Q3 2025.